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Background: Tendinopathy of the long head of the biceps brachii tendon (LHBT) 
is one of the most common, painful conditions of the anterior part of the shoulder 
and often coexists with rotator cuff tears. Multifactorial aetiopathology of tendi-
nopathy is poorly understood; however, several studies indicated that it is seen 
predominantly in areas with decreased vascularity of the tissue; the pathology is 
also characterised by expansive and abundant neovascular in-growth. The aim of 
the study was to investigate the relationship between the neovascularisation of 
proximal part of the LHBT and pain along the bicipital groove.
Materials and methods: Tissue material was obtained from 28 patients who 
underwent a shoulder arthroscopy and experienced pain along the bicipital groove 
measured using Visual-Analog Scale (VAS) score. CD31 and CD34 molecules were 
visualised by immunohistochemical method to assess biceps tendon neovascula-
risation and quantify it based on a Bonar scoring system.
Results: Although all patients reported pain prior to arthroscopy (mean VAS 
score was 7.5), microscopic examination did not reveal neovascularisation in all 
cases. Immunohistochemical staining for CD31 and CD34 allowed for very precise 
visualisation and quantification of neovascularisation; however there was also no 
correlation between vessels in-growth scores and pain.
Conclusions: The obtained data suggest that neovascularisation process in tendino-
pathy is not directly related to pain; however, further studies are needed to explain 
its significance in the LHBT tendinopathy. (Folia Morphol 2018; 77, 2: 378–385)
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INTRODUCTION
Tendinopathy of the long head of the biceps bra-
chii tendon (LHBT) is one of the most common causes 
of chronic anterior shoulder pain, typically localised 
within the bicipital groove on the proximal part of 
humerus, 3–6 cm below the anterior margin of the 
acromion [17, 18, 38]. Up to 90% of cases of the 
LHBT tendinopathies are accompanied by additional 
shoulder disorders, such as massive rotator cuff tears 
(RCTs); in numerous cases treatment of this condition 
is difficult [3, 12]. 
The aetiopathology of the LHBT tendinopathy 
is complex and not fully understood. One of most 
widely accepted theories of its development focuses 
on the vascular origin of the process. This theory is 
based on the assumption that a gradual degradation 
of tendons occurs predominantly in hypovascular or 
avascular regions, which are prone to subsequent 
hypoxia. This is supported by data from the literature, 
which indicates that certain tendons tend to fail in 
hypovascular or critical zones e.g. Achilles tendon, 
rotator cuff tendons, tibialis posterior tendon [13, 
31, 33]; similarly, in the LHBT a hypovascular area 
was demonstrated about 1–3 cm from its origin [12].
The degradation of tendinous tissue leads to 
significant changes in the histology of tendon. Mi-
croscopic findings include alterations in fibre align-
ment, cellular structure and collagen stain ability, as 
well as increased vascularity. Several facts suggest 
that the last aforementioned conditions could play 
an important role in mediation of pain related to 
the LHBT tendinopathy, where the vascular network 
tends to become substantially denser [8, 21, 34]. 
Newly formed vessels are followed by nerves, which 
usually arrive from the supraglenoid tubercle; their 
endings may contain increased levels of calcitonin 
gene-related peptide (CGRP) and substance P which 
are likely responsible for pain sensation [5]. 
Surprisingly, despite recent advances in imaging 
of the LHBT tendinopathy and the development of 
therapeutic strategies, relatively few studies have 
tried to quantify histological changes related to this 
condition. In most studies the evaluation has been 
based on semiquantitative Movin and Bonar scores, 
which require special staining protocols (GAG) and 
focus on several microscopic features of cells and 
extracellular matrix. Interestingly, despite the fact 
that neovascularisation seems to play an important 
role in the development of pain related to LHBT ten-
dinopathy, few studies have investigated the extent 
of this phenomenon or have tried to explain how it 
is related to clinical symptoms.
In recent years multiple publications have doc-
umented that two markers, CD31 and CD34, can 
be successfully used to visualise presence of newly 
formed vessels, especially in various types of tumours. 
CD31 is a 130 kDa trans-membrane glycoprotein 
present on the surfaces of: platelets, monocytes, 
macrophages, neutrophils, is a constituent of the 
endothelial intracellular junction and plays a role in 
adhesion of endothelial cells (EC) and in the angio-
genic process [29]. CD31 is expressed in 90% of EC 
tumours — it is generally regarded as the best single 
marker of EC differentiation. CD34 is a 110 kDa trans-
membrane glycoprotein present on leukemic cells, EC, 
and stem cells; it plays a role in angiogenesis and is 
considered a marker of vascular tumours [29].
Several authors suggested that these markers 
could aid in the diagnosis of non-vascular tumours 
and pathological neovascularisation [11, 27–29, 35]. 
That is why we conducted a study which could dem-
onstrate (1) whether it is possible to clearly visualise 
neovascularisation of the LHBT using CD31 and CD34 
markers, (2) if there is a relationship between the ex-
tent of LHBT neovascularisation and patient reported 
clinical symptoms.
MATERIALS AND METHODS
This study included 28 consecutive patients who 
underwent shoulder arthroscopy and were diag-
nosed, among other pathologies, with the LHBT ten-
dinopathy. The study was approved by local bioethics 
committee (approval no. KB 598/2016). All patients 
were volunteers and gave informed consent. We in-
cluded patients who were diagnosed based on clini-
cal examination (unilateral pain during palpation of 
the anterior part of the humerus, in the area of the 
bicipital groove; the minimal duration of symptoms 
was 3 months), sonographic studies or non-contrast 
magnetic resonance scans. In most cases the LHBT 
tendinopathy was associated with lesions of the ro-
tator cuff (19 patients); however, we did not include 
patients with rheumatic diseases, previous surgical 
treatment or corticosteroid injections in the past 
12 months. The mean age of the subjects was 52 years 
(28–74 years; standard deviation [SD] 10.5); the co-
hort included 13 males and 15 females. All patients 
underwent physical examination prior to surgery: 
anterior shoulder pain was evaluated using a Visual-
Analog Scale (VAS) with a scale from 0 (no pain) to 10, 
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(most severe pain). Additionally, we performed clinical 
test — tenderness over the bicipital groove.
Since obtaining samples of healthy LHBT tendons 
is problematic, as a negative control group we in-
cluded 4 patients who underwent anterior cruci-
ate ligament (ACL) reconstruction using hamstring 
tendons (semitendinosus, semimembranosus and 
biceps femoris muscles) [36]. From these patients we 
obtained fragments of the semitendinosus tendons 
which were discarded during preparation of the ACL 
graft. In order to confirm proper staining results 
of immunohistochemical studies, we also included 
positive controls — slides obtained from paraffin 
blocks which contained samples of 2 vascular tu-
mours. These samples were confirmed to contain 
CD31/CD34 immunopositive cells using a different 
batch of antibodies than used in this study.
Long head of the biceps brachii tendon samples 
were obtained during shoulder arthroscopies which 
was performed in the beach chair position in general 
anaesthesia. During the procedure, the LHBT was 
inspected for pathology and subsequently subjected 
to tenodesis or tenotomy. Next, the intra-articular 
part of the tendon was removed using arthroscopic 
scissors; the resection started about 1 cm from the 
origin at the supraglenoid tubercle and ended in the 
bicipital groove area. All obtained tissue fragments 
were immediately fixed in 10% buffered formalin; 
the remaining proximal part of the tendon was then 
vaporised. 
All tissue samples were dehydrated in increasing 
concentrations of ethanol, cleared in xylene, em-
bedded in paraffin and cut into 4 μm thick serial, 
longitudinal sections which were mounted on glass 
slides. One sample from each patient was stained 
using haematoxylin and eosin (H&E) procedure for 
routine histopathological examination, using opti-
cal microscopy. Subsequently, sections were stained 
using antibodies for CD31 (Roche, 760-4378, Sierra 
College Boulevard Rocklin, California, USA), and CD34 
(Roche, 790–2927, Hague Road, Indianapolis, USA). 
Briefly, sections were deparaffinised and rehydrated; 
endogenous peroxidase was blocked with 3% hydro-
gen peroxide. Next, samples were stained using a fully 
automated Ventana BenchMark GX (Rotkreuz, Swit-
zerland) according to manufacturer’s instructions; 
incubation with primary antibodies took 40 min.
The assessment of neovascularisation was based 
on the criteria from the Bonar scale [20, 22, 36]. The 
scores 0, 1, 2, 3 correspond to the following stages 
of neovascularisation seen in 10 high-power fields 
(HPFs): 0 — modest and average occurrence of the 
blood vessels, 1 — incidental cluster of capillaries less 
than 1 per 10 HPFs, 2 — indicates 1–2 clusters per 
10 HPFs, 3 — indicates more than 2 clusters per 10 
high-power fields. In each patient we analysed ten 
high-magnification fields which demonstrated pres-
ence of the densest capillary network.
Statistical analysis
Data were statistically analysed using Statistica 
12 software (Statsoft, Krakow, Poland). Normality of 
data distribution was evaluated using Saphiro-Wilk 




All patients included in this study reported an-
terior shoulder pain, which was moderate to severe 
(range 5–9 points), with a mean VAS score of 7.5 
(SD 0.92). Three patients reported presence of ante-
rior shoulder pain at night. A preoperative physical 
examination showed that palpation in the bicipital 
groove was painful in 26 patients (93%, 14 women 
and 12 men). The bicipital groove tenderness test was 
negative in 2 patients — one of them had a totally 
ruptured LHBT, in the other shoulder the tendon was 
not ruptured and the patient had moderate overall 
shoulder pain with VAS score of 5. During shoulder 
arthroscopy the LHBT tendinopathy was confirmed in 
all cases, mostly accompanied by other lesions: RCTs 
were seen in 19 patients, subacromial impingement in 
16 patients, labral defects in 2 patients. In 6 cases the 
LHBT lesion was treated with tenotomy, in 21 cases 
with tenodesis. There was one complete LHBT rupture 
which required the intra-articular stub resection. 
Macroscopic assessment of the removed LHBT por-
tions revealed several pathological features, among 
all of them: tears, widening and flattening of the 
resected tendon part. 
Microscopic evaluation of tendon samples
Microscopic evaluation of H&E stained slides 
showed advanced degeneration among all of the 
specimens; neovascularisation was observed in 22 
(78%) patients (Fig. 1B, C). We graded the neovascu-
larisation process, present in 22 specimens, according 
to the criteria adopted from the Bonar scale. Grade 0 
was present in 6 samples. Grades 1 and 2 were 
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identified in 5 and 8 samples, respectively. The high-
est grade — 3, was present in 9 samples and it was 
the most numerous group (Table 1, Fig. 2). In cases 
where neovascularisation was present, vessels were 
uniformly scattered in the tendon tissue, except for 
2 cases, where we noted formation of angio-fibrous 
granulation with massive formation of new vessels 
(Fig. 3). 
Immunohistochemical staining of vessels from 
LHBT samples using CD31 and CD34 antibodies dem-
onstrated a nearly identical profile of both antigens 
in all specimens (Fig. 4C, D). Both markers provided 
excellent visualisation of capillaries’ walls in tendon 
tissue as well as positive controls, allowing a precise 
quantification of neovascularisation process; negative 
controls did not exhibit any unspecific reactions or ar-
tifacts and contained very few capillaries (Fig. 4A, B). 
There were no differences between scores obtained 
after neovascularisation assessment in slides stained 
using CD31 and CD34 antibodies. 
Statistical analysis
Statistical analysis demonstrated that there was no 
correlation between VAS scores and the extent of neo-
vascularisation quantified in this study (Spearman’s 
coefficient = 0.233; significance level, p = 0.2323). 
Table 1. Distribution of pathological alterations among 28 patients
Patient number 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28
Visual-Analog 
Scale (VAS) score
8 7 8 5 6 7 6 7 8 7 7 8 8 8 8 8 7 8 7 7 8 7 8 9 9 8 7 9
Neovascularisation 
level according to 
Bonar score
2 2 3 0 1 1 0 0 1 3 2 3 2 3 3 3 0 2 1 3 2 2 0 1 2 3 3 0
Figure 1. Structure of normal and pathological tendon samples; haematoxylin and eosin staining. A. Normal tendon with wavy configuration 
of fibres and spindle-shaped nuclei (circles); magnification 100×; B. Long head of the biceps brachii tendon (LHBT) tendinopathy — disorgan-
ised fibrous structure visible in damaged areas (arrows), round nuclei (circles) typically seen in pathological tenocytes; magnification 100×; 
C. Neovascularisation in LHBT tendinopathy: a network of randomly scattered capillaries (arrows) is present among disorganised extracellular 
matrix; rounded nuclei of tenocytes are visible (circles). Solitary capillary vessels are forming organised groups of new vessels in the tendon 
tissue, called clusters; magnification 200×.
Six patients, with the absence of neovascularisation in 
samples, had anterior shoulder pain (VAS score 5–9). 
Additionally, in 5 of them the bicipital groove ten-
derness test was positive (Table 1). All patients with 
neovascularisation process of the LHBT demonstrated 
anterior shoulder pain (VAS score 6–9), interestingly 
one of these patients had a complete rupture of the 
tendon and did not demonstrate tenderness over the 
bicipital groove. Despite that fact, permanent pain-
ful disorders were present in the anterior area of the 
shoulder (VAS score 8).
DISCUSSION
In healthy tendons vascularisation is modest with 
a small number of capillaries located between bun-
dles. Vessels of the tendon arise mainly from the mus-
culotendinous junction, osteotendinous junction and 
connective tissue sheath [13]. Vessels are arranged 
mainly longitudinally to the long axis of the tendon. 
Tendons are metabolically active tissues and demand 
adequate blood distribution [1]. Tendon’s nutrition 
depends on synovial fluid delivery and blood supply 
from local vessels. Despite this, tendons are charac-
terised by a low vascular perfusion. 
The process of neovascularisation occurs in patho-
logical condition in tendons such as osteoarthritis, 
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retinopathy, inflammation, tumours. Presence of 
neovascularisation is well documented in advanced 
tendinopathies and can be demonstrated using Dop-
pler ultrasound examination [9, 15, 19, 20, 26, 30]. 
Similarly, in our study the presence of neovascularisa-
tion of the LHBT was confirmed in 78% of specimens. 
In recent studies, microdialysis techniques were used 
to obtain the extra-cellular fluid from tendons and ex-
amine presence of mediators associated with neovas-
cularisation [1]. High levels of lactate concentration 
Figure 3. Extraordinary, abundant formation of new vessels in the 
long head of the biceps brachii tendon. Staining haematoxylin and 
eosin; magnification 100×.
Figure 4. Immunohistochemical examination of neovascularization. A. CD31 — positive control, Hemangioma capillare simplex — arrows 
indicate positive reaction which corresponds to vascular walls; magnification 200×; B. CD34 — positive control, Hemangioma capillare  
simplex — arrows indicate positive reaction corresponding to vascular wall; magnification 200×; C. CD31 staining — long head of the  
biceps brachii tendon (LHBT) tendinopathy; arrows indicate expression of newly formed capillaries arranged in a random pattern;  
magnification 200×; D. CD34 staining — LHBT tendinopathy, arrows indicate expression pattern of randomly scattered capillaries  
in disorganised extracellular matrix; magnification 200×.
Figure 2. Comparison of neovascularisation process and pain in-
tensity. Scatter plot showing relationship between neovascularisa-
tion and painful disorders according to Visual-Analog Scale (VAS) 
score among patients.
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were found in tendons of patients suffering from ten-
dinopathy, which indicates insufficient vascular sup-
ply and is associated with anaerobic metabolism [4]. 
Hypoxia leads to increased synthesis of vascular en-
dothelial growth factor (VEGF), which is an important 
angiogenesis regulator and has an influence on ten-
don’s proteases activity [1]. This is accompanied by 
increased synthesis of matrix metalloproteases, which 
degrade tendons structure to facilitate expansion of 
new vessels. VEGF level is also elevated during the 
regeneration of tendon tissue, after the inflammatory 
phase, during formation and remodelling phases [24]. 
Interestingly, recent studies showed that other forms 
of mechanical stimuli such as massage, can also initi-
ate structural changes in tendons and muscles. Using 
a rat model, Andrzejewski et al. [6, 7] demonstrated 
that short-term massage can up regulate VEGF in 
skeletal muscles, while long-term massage can induce 
structural changes in the structure of collagen fibres. 
Other animal studies of tendons subjected to acute 
injuries, demonstrated presence of neovascularisation 
in such cases, which suggests that it is associated 
with healing response [23, 32]. Since it is difficult 
to obtain such specimens from patients with fresh 
tendon injuries, most publications focus on chronic 
injuries [9, 15, 26, 39]. These reports indicated that 
despite formation of new vessels, there is no healing 
response. Instead, most authors reported accumula-
tion of new vessels accompanied by a network of 
altered tenocytes unable to maintain the organised 
structure of the extracellular matrix [40].
Isolated pathology of the LHBT is relatively rare 
and seen predominantly in young throwing sports 
athletes. In most cases it affects non-athletes and 
coexists with overuse trauma and other shoulder 
pathologies, such as subacromial impingement, RCTs, 
superior labral tear from anterior to posterior [16, 
37, 38, 40]. Consequently it was suggested that an-
terior shoulder pain may not result strictly from LHBT 
pathology but is rather a manifestation of complex 
shoulder lesions [36]. Still, the role of the LHBT in an-
terior shoulder pain is undeniable, since arthroscopic 
tenotomy and tenodesis procedures usually result in 
pain relief [17, 36].
This is consistent with observations from our study, 
where vessels formation was not directly associated 
with painful condition of the tendon demonstrated 
using the VAS scale. Similar findings were reported 
by Singaraju et al. [36], who used VAS score for the 
assessment of painful conditions in the course of the 
LHBT tendinopathy. Other authors reported that the 
LHBT tendinopathy related symptoms are night-pains, 
often expanding to arm and radiating longitudinally; 
however, in our group this symptom was seen in 
fewer patients than in other authors’ data [3]. 
As mentioned previously, patient-reported symp-
toms are not specific to LHBT lesions; unfortunately 
the same can be said about numerous clinical tests 
for the LHBT [40]. The most accurate and the simplest 
test is the tenderness over the bicipital groove. In 
our study tenderness over the bicipital groove was 
negative for 2 subjects — one patient had a low VAS 
score (5 points) and absence of neovascularisation 
process, another patient had a complete LHBT rupture 
and probably it confused the clinical examination; 
this patient also had high neovascularisation grade 
and VAS scores (grade 3 and 8 points, respectively). 
Moreover, 6 patients with no neovascularisation re-
ported anterior shoulder pain (VAS score 5–9) and 
5 of them had bicipital groove tenderness. Although 
these patients had concurrent intra-articular lesions: 
RCTs, subacromial impingement and acromio-cla-
vicular joint dysfunction, we cannot unequivocally 
explain the discrepancy between clinical and micro-
scopic findings in these cases. The bicipital groove is 
covered by other structures and lies in the proximity 
of supraspinatus tendon and subscapularis tendon 
insertion [37]. Additionally, examination of obese or 
muscled patients is becoming difficult. All mentioned 
features complicate the physical examination [37].
One of possible explanations of pain related to 
LHBT lesions comes from the fact that advanced 
tendinopathy is usually associated with rich angio-
fibroblastic reaction accompanied by neoinnervation 
[39]. Nerve endings secrete substances named neuro-
transmitters that are responsible for pain sensation. It 
is thought that chronic painful disorders are a result of 
uncontrolled release of the neurotransmitters which 
may lead to disruption of the homeostasis [25]. The 
presence of the neurotransmitters and their connec-
tions with pain were demonstrated in other tendons 
[2, 5]. Nociceptive nerve endings were often found 
close to vessels and pain mediators, e.g. substance P 
and CGRP appeared in proximity to blood vessels [26]. 
Similarly, Singaraju et al. [36] who examined for-
mation of new nerves in LHBT tendinopathy using 
markers of substance P and CGRP did not demon-
strate a clear relationship between microscopic and 
clinical findings. Their findings are consistent with 
our study and could suggest that pain is related to 
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functional changes in these endings, and not directly 
related to the number of the endings. This also indi-
cates, that the LHBT tendinopathy is not a sole cause 
of the anterior shoulder pain and more structures may 
be involved in this process.
Chronic tendinopathy is widely described as 
a painful process, with a new vessels expansion in 
a failed attempt to regenerate the tendon, which 
leads to an increased number of disorganised capil-
laries. In order to allow for a clear visualisation of 
this process, we decided to conduct immunohis-
tochemical staining CD31 and CD34. This method 
demonstrated continuous and regular expression of 
both markers, which did not appear beyond vessels, 
allowed us to evaluate in-growth of the new capil-
lary vessels and proved to be useful as markers of 
neovascularization process in tendons’ pathology. 
Our control group of healthy semitendinosus ten-
dons did not revealed neovascularisation process 
and on the other hand, a control group of vascular 
tumours specimens was characterised by rich and 
clear CDs immunostaining. Although Pusztaszeri et 
al. [29] described heterogeneous expression of CD31 
and CD34 in different tissues of the human body and 
demonstrated that it may be related to ageing, we 
did not demonstrate such an effect in our material.
Feasibility of these markers in visualisation of neo-
vascularisation in tendinopathies was also demon-
strated by other authors. Kragsnaes et al. [20] success-
fully used CD34 staining in specimens obtained from 
Achilles tendons affected by chronic tendon disease 
and tendons obtained from healthy volunteers. They 
have noted that immune-competent cells prevailed in 
the majority of the specimens which were obtained 
from degenerated tendons. Fields of the positive 
CD34 reaction were present predominantly in tendons 
affected by tendinopathy. Another study by Xu et al. 
[39] reported the presence of positive reaction of the 
endothelial cell markers in rotator cuff tendons af-
fected by chronic disorder and the negative reaction 
in healthy subscapularis tendons. It must be however 
emphasized that other neovascularisation markers, 
such as factor VIII-related antigen, CD105, smooth 
muscle actin have also been proposed [10, 14].
The main limitation to our study was investigation 
of patients without isolated LHBT tendinopathy. The 
LHBT tendinopathy is usually associated with at least 
one important shoulder pathology. Tendons obtained 
from humans usually represent advanced pathologi-
cal process and there is limited access to patients in 
the initial phase of the disorder. It must be however 
underlined that such limitations were also reported 
by other authors, and currently no other methods 
are available to study the role of neoangiogenesis in 
humans [36]. Another weakness comes from the fact 
that the group of patients included in this study was 
relatively small and non-homogenous. Additionally, 
since we did not harvest parts of the tendon adja-
cent to its insertion, we were unable to study neo-
vascularisation in this part, which could potentially 
be characterised by a denser network of capillaries 
arising from the supraglenoid tubercle. 
CONCLUSIONS
Our study confirmed that neovascularisation is 
a common process in the course of the LHBT tendi-
nopathy. We demonstrated that immunohistochemi-
cal techniques using CD31 and CD34 markers allow 
for a clear visualisation of newly formed capillaries. 
However, although it is thought that new vessels 
formation is accompanied by the neural tissue in-
growth and release of the neurotransmitters, we 
were unable to demonstrate a relationship between 
microscopic findings and pain level in our patients. 
This suggests that anterior shoulder pain is a complex 
phenomenon, which involves pathologies of the LHBT 
and concomitant structures. Since we demonstrated 
that clinical examination may not be sufficient to pre-
cisely diagnose LHBT tendinopathy, we are strongly 
convinced that subsequent studies are needed to gain 
insight into the relationship between tendinopathy, 
neovascularisation and pain.
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